SCHEMBL7400907

SCHEMBL7400907

Cc1cc(C(C)Oc2ccc(C(=O)NCCC(=O)NO)cc2)c2ccccc2n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
ADAM17 P78536 8/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
ADAM10 O14672 1/20 0.45
MMP1 P03956 1/20 0.45
MAPT P10636 1/20 0.45
MMP2 P08253 1/20 0.45
GCG P01275 1/20 0.44
ADAMTS4 O75173 2/20 0.44
MMP3 P08254 2/20 0.44
MMP7 P09237 2/20 0.44
ADAMTS1 Q9UHI8 2/20 0.44
ADAMTS5 Q9UNA0 2/20 0.44
MMP8 P22894 1/20 0.44
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7402599 0.85 ADAM17 (0.55) SMN1; SMN2ADAM17MEN1KMT2AKDM4E
SCHEMBL7405002 0.83 SMN1; SMN2 (0.51) SMN1; SMN2ADAM17MEN1KMT2AKDM4E
SCHEMBL7403682 0.83 ADAM17 (0.53) SMN1; SMN2ADAM17MEN1KMT2AKDM4E
SCHEMBL7404740 0.82 SMN1; SMN2 (0.50) SMN1; SMN2ADAM17ADAM10MMP1MMP2
SCHEMBL6598359 0.82 ADAM17 (0.70) ADAM17ADAM10MMP1MMP2ADAMTS4
SCHEMBL7403617 0.81 SMN1; SMN2 (0.44) SMN1; SMN2ADAM17KDM4EADAMTS4MMP3
SCHEMBL6629887 0.80 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AKDM4EALDH1A1
SCHEMBL7402889 0.80 MMP2 (0.44) ADAM17MMP2
SCHEMBL7400903 0.80 ADAM17 (0.58) SMN1; SMN2ADAM17ADAM10MMP1MMP2
SCHEMBL7407963 0.80 ADAM17 (0.48) SMN1; SMN2ADAM17ADAM10MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed